XJPX4014
Market cap17mUSD
Dec 30, Last price
440.00JPY
1D
3.04%
1Q
-24.66%
IPO
-72.31%
Name
Karadanote Inc
Chart & Performance
P/E
24.10
P/S
1.26
EPS
18.26
Div Yield, %
0.00%
Shrs. gr., 5y
0.91%
Rev. gr., 5y
28.04%
Revenues
2.19b
+6.69%
Net income
115m
P
CFO
-107m
L-57.96%
Earnings
Mar 13, 2025
Profile
Karadanote Inc. plans and develops applications related to pregnancy, childbirth, and childcare for medication and health management. It also provides media planning and management services; and insurance agency services. The company was incorporated in 2008 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2024‑07 | 2023‑07 | 2022‑07 | 2021‑07 | 2020‑07 | 2019‑07 | 2018‑07 | |
| Income | |||||||
Revenues | 2,193,966 6.69% | 2,056,447 57.45% | 1,306,130 30.35% | ||||
Cost of revenue | 711,315 | 2,194,240 | 1,509,219 | ||||
Unusual Expense (Income) | |||||||
NOPBT | 1,482,651 | (137,793) | (203,089) | ||||
NOPBT Margin | 67.58% | ||||||
Operating Taxes | (15,031) | (1,188) | 7,321 | ||||
Tax Rate | |||||||
NOPAT | 1,497,682 | (136,605) | (210,410) | ||||
Net income | 114,890 -142.23% | (272,060) 0.12% | (271,732) -295.41% | ||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | 7,200 | 6,485 | (75,910) | ||||
BB yield | -0.22% | -0.14% | 1.37% | ||||
| Debt | |||||||
Debt current | 100,000 | 100,000 | 100,000 | ||||
Long-term debt | 200,000 | 300,000 | 400,000 | ||||
Deferred revenue | |||||||
Other long-term liabilities | 5,204 | 5,205 | 5,206 | ||||
Net debt | (183,476) | (304,646) | (556,324) | ||||
| Cash flow | |||||||
Cash from operating activities | (107,369) | (255,409) | (346,912) | ||||
CAPEX | (2,814) | (2,168) | |||||
Cash from investing activities | (3,000) | (2,815) | (3,793) | ||||
Cash from financing activities | (92,800) | (93,453) | 424,089 | ||||
FCF | 1,186,198 | (58,000) | (273,190) | ||||
| Balance | |||||||
Cash | 483,476 | 686,646 | 1,038,324 | ||||
Long term investments | 18,000 | 18,000 | |||||
Excess cash | 373,778 | 601,824 | 991,018 | ||||
Stockholders' equity | 17,807 | 171,263 | 433,179 | ||||
Invested Capital | 640,047 | 370,514 | 684,824 | ||||
ROIC | 296.41% | ||||||
ROCE | 225.38% | ||||||
| EV | |||||||
Common stock shares outstanding | 6,275 | 6,222 | 6,236 | ||||
Price | 533.00 -30.05% | 762.00 -14.38% | 890.00 -32.83% | ||||
Market cap | 3,344,559 -29.46% | 4,741,440 -14.57% | 5,550,252 -30.71% | ||||
EV | 3,161,083 | 4,436,794 | 4,994,928 | ||||
EBITDA | 1,482,951 | (137,469) | (196,823) | ||||
EV/EBITDA | 2.13 | ||||||
Interest | 1,950 | 2,522 | 369 | ||||
Interest/NOPBT | 0.13% | ||||||